SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-067376
Filing Date
2017-12-27
Accepted
2017-12-27 13:35:35
Documents
2
Period of Report
2017-12-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2673
2 POA DOCUMENT poa.txt EX-24.3_758636 3906
  Complete submission text file 0001209191-17-067376.txt   8013
Mailing Address C/O TULARK INC TWO CORP DRIVE S SAN FRANCISCO CA 94080
Business Address
MCKNIGHT STEVEN L (Reporting) CIK: 0001182470 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38327 | Film No.: 171275832

Mailing Address 675 W. KENDALL STREET CAMBRIDGE MA 02142
Business Address 675 W. KENDALL STREET CAMBRIDGE MA 02142 617-949-2680
Cue Biopharma, Inc. (Issuer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations